All posts Analysts Pharma and Biotech blu Bellus Health shareholders should take the deal,... April 18, 2023 Jayson MacLean Shareholders should take the acquisition offer just announced for Canadian...
All posts Analysts Pharma and Biotech blu Bellus Health gets a target drop from... February 25, 2022 Geordie Carragher Research Capital Corporation analyst André Uddin thinks Bellus Health (Bellus...
All posts Analysts Health Life Sciences blu Bellus Health scores big target raise from... September 20, 2021 Geordie Carragher Research Capital analyst André Uddin has revised his view on...
All posts Analysts Life Sciences blu Bellus Health upgraded at Research Capital July 26, 2021 Geordie Carragher Research Capital Corporation analyst André Uddin has revised his view...
All posts Analysts Life Sciences blu Bellus Health keeps “Hold” rating at Mackie... September 9, 2020 Nick Waddell Mackie Research analyst André Uddin reviewed the state of affairs...
All posts Analysts Life Sciences Trending blu Bellus Health downgraded by Mackie Research July 6, 2020 Nick Waddell Negative top-line results from its Phase 2 clinical study are...
All posts Life Sciences BELLUS Health has more upside left, Mackie... March 23, 2020 Nick Waddell Its chart is one of the rare ones that doesn’t...
All posts Analysts Life Sciences Trending blu Bellus Health is a double from here,... March 17, 2020 Jayson MacLean Mackie Research analyst André Uddin is holding steady with Bellus...